Taking aspirin for a long period helps to reduce the risk of developing skin cancer in Caucasian women. Data were obtained by scientists from the United States and published in the journal of the American Cancer Society CANCER.
The study included the participation of about 60,000 white-skinned women between the ages of 50 and 79 years who were under the supervision of scientists for over 12 years. All of the women reported receiving information about medications, diet and way of their activities.
As a result, a team of researchers led by Dr. Gina Tan (Jean Tang) School of Medicine, Stanford University in Palo Alto (Palo Alto) found that women who took aspirin in large numbers, others were less susceptible to skin cancer. Reducing the risk of added up to 21% compared with participants who did not take aspirin. A patient who used aspirin for five years or more, fell ill melanoma by 30% less.
The scientists were also taken into account in the work of such risk factors for skin cancer, the use of means of protection from the sun and tanning.
"Aspirin reduces inflammation in the body and this may explain the reduced risk of developing melanoma," - said Dr. Tan.
Other pain medications at the same time (eg, acetaminophen) had no effect on reducing the risk of melanoma. However, clinical studies are needed to accurately determine whether taking aspirin in the prevention of skin cancer, the authors stress.